PFE

Pfizer Inc.

$29.21

Current Price

All

AI analysis

Read what the AI thinks of Pfizer Inc. in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

$1.57

Yield

5.38%

EPS

$0.76

P/E

38.0

Data as of Oct 1

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings

Expected EPS: $0.75

Nov 3

Posts

Treasury drafts a China pharma exception as tech ties tighten

3w ago

Sector

About Pfizer Inc.

Pfizer is one of the world's largest drugmakers. It researches, manufactures, and sells prescription medicines and vaccines for conditions ranging from cancer and heart disease to infections, and it still earns meaningful revenue from its COVID-19 vaccine Comirnaty and antiviral Paxlovid. Beyond direct drug sales, Pfizer also collects "alliance revenue," its cut from co-marketing deals with partners like BioNTech.